Biohit and Eurobio to sign a distributor agreement Biohit

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Biohit and Eurobio to sign a distributor agreement

Biohit Oyj Press Release December 22, 2014 at 3 pm. local time (EET)  

Biohit Oyj and Eurobio have signed a distributor agreement regarding diagnostic tests of Biohit. The agreement is effective immediately, and Eurobio gains exclusive rights for the distribution of diagnostic tests in France, Morocco, Tunisia and Algeria. The agreement covers the following Biohit tests: GastroPanel®, Helicobacter Pylori UFT300 Quick Test, Biohit Active B12 vitamin test, ColonView Quick Test, Lactose Intolerance Quick Test and Celiac Disease Quick Test.

GastroPanel® is a non-invasive test for stomach health. The test diagnoses H. pylori infection and atrophic gastritis, caused by Helicobacter pylori infection or autoimmune disease. These results can be used to assess whether patients have risk of gastric and esophageal cancer, peptic ulcer disease or risk of vitamin B12-, calcium- and iron malabsorption and if eventual  further examinations  are needed (attachment: additional information).

Helicobacter Pylori UFT300 Quick Test is a true quick test for the detection of H. pylori from a biopsy specimen. Helicobacter Pylori UFT300 Quick Test has excellent sensitivity and specificity which makes it a highly accurate tool for H. pylori diagnostics.

Biohit Active B12 vitamin test measures the level of biologically active B12 vitamin from a blood sample. Vitamin B12 deficiency can occur in seemingly healthy people, and the risk increases with age. The test does not measure the level of total B12, but it measures the level of active form of vitamin B12, holotranscobalamin, available for the cells.

ColonView Quick Test is a diagnostic test for screening of colorectal cancer (CRC). This sensitive test detects fecal occult blood derived from both the upper and lower gastrointestinal tract - with improved sensitivity for even small benign lesions (polyps) and cancer precursors (adenomas).

The Lactose Intolerance Quick Test developed by Biohit for rapid diagnosis of lactose intolerance (hypolactasia of the small intestine) is based on the activity of the lactase enzyme in a duodenal biopsy specimen. Celiac Disease Quick Test measures gluten antibodies in serum and negative results exclude celiac disease.  The test will bring clear benefits in healthcare costs, because it reduces the number of unnecessary endoscopies.

CEO Semi Korpela, Biohit Oyj: ’This is an outstanding opening for French speaking market area. Eurobio offers us a high-grade partnership with well-established market position on the chosen area.’

Managing Director and owner Denis Fortier, Eurobio: ‘We are very happy to sign this agreement with Biohit, and are looking forward to develop this business together. This new range of products will open new perspectives and challenges to our current catalogue and considerably develop our positioning in innovative markers.’

Additional information: CEO Semi Korpela, Biohit Oyj tel. +358 9 773 861 investor.relations@biohit.fi www.biohithealthcare.com

Attachment: additional information  

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com

Eurobio in brief

For almost fifty years, Eurobio has been present on in-vitro diagnostic and life science markets, which makes it a reknown society in the development, making and marketing of high-quality, innovative in-vitro diagnostic. Besides, this experience in diagnostic and life science products allows the company to develop and to offer complete solutions for laboratories and for biotechnology, research and pharmaceutical laboratories. Today, Eurobio has the ambition to stand as one of the greatest French innovative products distributors. Eurobio is one the leaders on the french in-vitro diagnostic market. The company is located at Les Ulis, northwest from Paris. www.eurobio.fr

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AppLovin Faces Legal Heat: Investors on Edge Today

Updated Category News Views 26

AppLovin's Day of Reckoning: Investors Take Note Ever find yourself caught in a whirlwind of corporate promises that slide into disappointment? Well, buckle up, because that's exactly where AppLovin finds itself today. They've stirred up a storm with investors over some questionable hyperbole about their artificial intelligence tools and ad services. Missteps and Market...

Continue Reading
Teledyne LeCroy Drives AI Scale-up with New UALink

Updated Category News Views 17

Pushing the Boundaries of AI Infrastructure Teledyne LeCroy is shaking things up with their latest innovation—the Xena Z2244 Ultra Accelerator Link™ Traffic Generator, a tool that promises to turbocharge validation systems for AI and HPC scale-up infrastructure. If you're dealing with the nuts and bolts of next-gen networks, this one's worth your attention. Setting a...

Continue Reading
Medtronic's Bold Move to Own Carotid Market Full-Scale

Updated Category News Views 150

When a giant like Medtronic makes a move, you can bet investors take notice, and this latest acquisition is no exception. They’re reaching into their deep pockets to acquire Contego Medical, a company shaking up the world of carotid artery disease treatments. It’s a tactical strike to solidify their leadership in cardiovascular solutions. Medtronic's Bet on Innovation...

Continue Reading
Atomera Preps for Key Craig-Hallum Conference

Updated Category News Views 59

Unpacking the NYC Gathering Alight, let's comb through the moving parts here. Atomera Inc., ticker NASDAQ: ATOM for those eyeing the dance of numbers, is all set to step into the limelight at the 17th Annual Craig-Hallum Alpha Select Conference on November 17, 2026. This shindig isn't just another date on the calendar; it's a strategic haunt where Atomera will rub...

Continue Reading
Mastering Prescription Labels: Critical Insights for Safety

Updated Category News Views 45

Revolutionizing How We Approach Prescription Labels Prescription labels aren't just scraps of paper or stickers slapped on bottles; they're lifelines. The insight from pharmacy expert Sheldon Birch could turn a regular label into a powerful tool for health management. According to Birch, the label is often disregarded yet speaks volumes about the medication you've got in...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 278

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Net Zero Efforts to Cost Europe €60B Annually by 2050

Updated Category News Views 100

Hefty Prices Loom Over Net Zero Commitments Well, strap in for a wallet buster, folks. Europe's largest players are staring down the barrel of a colossal €60 billion annual bill to clean up their carbon mess by 2050. That's the ticker in Senken's latest report, 'Pace of Change 2026.' Talks like these remind me there's no such thing as a free lunch, especially when...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 71

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
Africa Tech Festival 2026: A Digital Turning Point

Updated Category News Views 109

Setting the Stage for Digital Advancement in Africa Come mid-November, Cape Town's gonna be buzzing with the clatter of tech titans and financial honchos making their annual pilgrimage to the Africa Tech Festival. This ain't just a conference shindig—with names like Naspers, MTN, Meta, and Amazon on the docket, it's a darn convention shaping the continent's future...

Continue Reading
OFRM Faces Legal Heat Over Toddler Snack Recall

Updated Category News Views 12

OFRM Under the Microscope: Who Saw This Coming? Smack dab in the middle of navigating everyday market volatility, here's Once Upon A Farm (NYSE: OFRM) taking the spotlight—but for all the wrong reasons. The company got slapped with a stark FDA warning. Their Tractor Wheels toddler snacks allegedly pose a choking risk— think 'dry, sticky mass' refusing to budge with...

Continue Reading

Top 5 Most Recently Viewed Articles

Octopus AIM VCT plc Announces Securities Purchase Update

Updated Category News Views 173

Overview of Recent Securities Purchase by Octopus AIM VCT plc Octopus AIM VCT plc has made a significant move in the investment landscape with its recent transaction involving the purchase of its own securities. This strategic decision, which involved the cancellation of 723,329 ordinary shares, highlights the company's commitment to managing its capital structure...

Continue Reading
Bradford T Whitmore Makes Significant Investment in Ultralife

Updated Category News Views 116

Notable Insider Investment in Ultralife It recently came to light through official filings that Bradford T Whitmore, a Board Member of Ultralife (NASDAQ: ULBI), has made a substantial insider purchase. This move of buying shares resonates with his confidence in the company's growth trajectory. Understanding the Purchase Whitmore's investment entailed the acquisition of...

Continue Reading
Innovative Partnership to Enhance Youth Care in California

Updated Category News Views 202

Transforming Youth Care Through Innovation Qualifacts, a prominent leader in AI-driven electronic health record (EHR) software, has announced an exciting partnership with Open Line Group Homes. This collaboration aims to revolutionize the billing procedures and operational workflows within residential care facilities catering to youth. With the growing need for efficient,...

Continue Reading
Achilles Therapeutics Transfers Key Assets to AstraZeneca

Updated Category News Views 184

Achilles Therapeutics Transfers Key Assets to AstraZeneca - Proprietary data and samples from TRACERx and Achilles' Material Acquisition Platform (MAP) will be transferred to AstraZeneca under the Transaction - - Conclusion of Strategic Review - Recently, Achilles Therapeutics plc (ACHL) announced a pivotal deal, transferring the commercial license of essential data and...

Continue Reading
Insights into Opendoor Technologies (OPEN) Market Performance

Updated Category News Views 311

Recent Developments in Opendoor Technologies Stock Opendoor Technologies Inc (NASDAQ: OPEN) has been capturing investors' attention recently, showcasing a compelling rally that illustrates a resurgence of optimism. The stock, known for its dynamic trading patterns, experienced a significant upswing, climbing more than 50% within just a week. This movement brought its...

Continue Reading